Provided by Tiger Trade Technology Pte. Ltd.

Purple Biotech Ltd.

1.52
-0.0500-3.18%
Volume:6K
Turnover:9.49K
Market Cap:2.47M
PE:-0.05
High:1.54
Open:1.54
Low:1.52
Close:1.57
52wk High:23.60
52wk Low:1.16
Shares:1.63M
Float Shares:927.10K
Volume Ratio:1.21
T/O Rate:0.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-28.8060
EPS(LYR):-54.9640
ROE:-111.13%
ROA:-20.31%
PB:0.20
PE(LYR):-0.03

Loading ...

Press Release: Purple Biotech Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 07

Purple Biotech Ltd Expected to Post a Loss of 40 Cents a Share - Earnings Preview

Reuters
·
Jul 31

Purple Biotech Says Preclinical Study Supports Advancing IM1240 to First-in-Human Trial in 2027

MT Newswires Live
·
Jun 11

Purple Biotech presents new IM1240 data at EACR

TIPRANKS
·
Jun 11

Purple Biotech files $200M mixed securities shelf

TIPRANKS
·
May 21

Purple Biotech Ltd reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 19

Analysts Are Bullish on These Healthcare Stocks: Purple Biotech (PPBT), Satellos Bioscience (MSLE)

TIPRANKS
·
May 18

Purple Biotech Ltd expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
May 15

Purple Biotech announces collaboration with Converge Bio

TIPRANKS
·
Mar 25

Purple Biotech Is Building What Could Be the Next Generation of Cancer Immunotherapy (NASDAQ: PPBT)

TIPRANKS
·
Mar 20

Patent Cliff Risk: How Expiring Protections Threaten Purple Biotech’s Future Exclusivity and Returns

TIPRANKS
·
Mar 20

Purple Biotech regains compliance with Nasdaq

TIPRANKS
·
Mar 17

Israel's Purple Biotech Q4 net loss widens on impairment charge

Reuters
·
Mar 13

Press Release: Purple Biotech Reports Fourth Quarter and Full Year 2025 Financial Results

Dow Jones
·
Mar 13

Purple Biotech Ltd expected to post a loss of $3.40 a share - Earnings Preview

Reuters
·
Mar 13

NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 07:59 PM

Reuters
·
Feb 28

Purple Biotech trading halted, news pending

TIPRANKS
·
Feb 28

Purple Biotech Ltd expected to post a loss of 34 cents a share - Earnings Preview

Reuters
·
Feb 27